Citations 513
Comparison of Treatment-Emergent Adverse Events of Covalent BTK Inhibitors in Clinical Trials in B-Cell Malignancies: A Systematic Review and Meta-Analysis
Wang, Jacqueline F, Jiang, Yi , Qi, Xinyue , Hampel, Paul J. , Leis, José F., Thanarajasingam, Gita , Inwards, David J. , Nowakowski, Grzegorz S. , Ansell, Stephen M. , Wang, Jacqueline , Wang, Jacqueline F , Hwang, Steven R. , Zhang, Shijia , Parikh, Sameer A. , Ding, Wei , Kenderian, Saad S. , Muchtar, Eli , Muñoz, Javier , Paludo, Jonas , Habermann, Thomas M. , Witzig, Thomas E. , Kay, Neil E. , Zhou, Shouhao , Wang, Yucai
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9882-9884
A Multi-Center Study: Outcomes Among Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients with CD20 Loss
Takiar, Radhika , Ng, Wern Lynn , Shah, Eshana, Boonstra, Philip S. , Karimi, Yasmin , Zamalloa, Carlos A. Murga, Nowakowski, Grzegorz S. , Karimi, Yasmin H , Carty, Shannon A. , Wilcox, Ryan A. , Phillips, Tycel
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9510-9511
Development of a Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma
Zhengming, Chen, Jakobsen, Lasse Hjort , El-Galaly, Tarec Christoffer Christoffer, Flowers, Christopher R. , Lossos, Izidore S. , Nowakowski, Grzegorz S. , Friedberg, Jonathan W. , Leonard, John P. , Smedby, Karin E. , Luan, Danny , Maurer, Matthew J. , El‐Galaly, Tarec Christoffer , Nastoupil, Loretta J. , Cerhan, James R. , Link, Brian K. , Stephens, Deborah M. , Habermann, Thomas M. , Bartlett, Nancy L. , Kahl, Brad S. , Brown, Peter de Nully , Jerkeman, Mats , Martin, Peter
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1921-1923
Incidence of Second Primary Malignancies in Lymphoma Survivors: A Prospective Cohort Study in the Modern Treatment Era
Mwangi, Raphael , Nowakowski, Grzegorz S. , Thompson, Carrie A. , Desai, Sanjal H. , Wang, Yucai , Farooq, Umar , Mou, Eric , Feldman, Andrew L. , Syrbu, Sergei , Slager, Susan L. , Maurer, Matthew J. , Kay, Neil E. , Habermann, Thomas M. , Link, Brian K. , Cerhan, James R.
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1934-1936
Outcomes with Immunochemotherapy Plus Radiation Versus Immunochemotherapy Alone in Stage I Diffuse Large B-Cell Lymphoma: A Retrospective Study
Ng, Wern Lynn , Bock, Allison M. , Wert, Yijin, Ng, Lay She , Nowakowski, Grzegorz S. , Kovalenko, Iuliia , Wang, Yucai
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3829-3830
Time to Complete Response within 24 Months As a Good Surrogate Marker of 8 Year-Progression Free Survival in Extranodal Marginal Zone Lymphoma
Conconi, Annarita , Nowakowski, Grzegorz S. , Thiéblemont, Catherine , Bommier, Côme , Zucca, Emanuele , Cerhan, James R. , Lambert, Jérôme
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3583-3584
Clinical Outcomes in Patients with Mantle Cell Lymphoma Who Received Autologous Stem Cell Transplant in the Second Line Setting
Bock, Allison M. , Tawfiq, Reema, Poonsombudlert, Kittika , Maliske, Seth , Kabat, Brian, Gysbers, Brianna, Smith, Katherine E. , Inwards, David J. , Ansell, Stephen M. , Nowakowski, Grzegorz S. , Smith, Katherine E R , Gile, Jennifer , Larson, Melissa C. , Maurer, Matthew J. , Cerhan, James R. , Hwang, Steven R. , Paludo, Jonas , Habermann, Thomas M. , Ayyappan, Sabarish Ram , Witzig, Thomas E. , Farooq, Umar , Wang, Yucai
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6517-6519
Evaluating the Impact of Lab-Based Eligibility Criteria By Race/Ethnicity in Frontline Clinical Trials for Diffuse Large B-Cell Lymphoma (DLBCL): A LEO Cohort Analysis
Khurana, Arushi , Mwangi, Raphael , McDonnell, Timothy J. , Riska, Shaun M., Lossos, Izidore S. , Flowers, Christopher R. , Nowakowski, Grzegorz S. , Nastoupil, Loretta J. , Reagan, Patrick Michael , Farooq, Umar , Romancik, Jason T. , Kahl, Brad S. , Martin, Peter, Witzig, Thomas E. , Cerhan, James R. , Maurer, Matthew J.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2056-2058
Molecular Landscape of Primary Refractory DLBCL
Bock, Allison M. , Wenzl, Kerstin , Stokes, Matthew E. , Hopper, Melissa A. , Dropik, Abigail R. , Sarangi, Vivekananda , Huang, C. Chris , King, Rebecca L. , Ansell, Stephen M. , Gandhi, Anita K. , Nowakowski, Grzegorz S. , Novak, Anne J. , Novak, Joseph P. , Krull, Jordan E. , Ortiz, Maria, Stong, Nicholas , Maurer, Matthew J. , Godby, Richard , Farooq, Umar , Wang, Yucai , Habermann, Thomas M. , Cerhan, James R.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9221-9223
Phase 1b Trial of Cereblon-Modulating Agents Iberdomide and CC-99282 Plus R-CHOP in Previously Untreated Aggressive B-Cell Lymphoma
Yeh, Su‐Peng , Gkasiamis, Argyrios, Patah, Poliana, Patel, Arpankumar , Nowakowski, Grzegorz S. , Westin, Jason R. , Martı́n, Alejandro , Hoffmann, Marc Steven , Vassilakopoulos, Theodoros P. , Li, Ju
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9475-9477